-
Comprehensive Investigation of Circulating Biomarkers and their Causal Role in Atherosclerosis-related Risk Factors and Clinical EventsD Zanetti , S Gustafsson, E Ingelsson et al. -
When, where, and how to target vascular inflammation in the post-CANTOS era?Maffia P, Guzik TJ.
-
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 DiabetesSR Das, BM Everett, KK Birtcher et al.
-
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?MS Madhur, F Elijovich, MR Alexander et al.
-
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)KC Koskinas, S Windecker, G Pedrazzini et al.
-
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of CardiologyDM Lloyd-Jones, LT Braun, CE Ndumele et al.
-
SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote AtherosclerosisLZ Huang, KL Chambliss, PW Shaul et al.
-
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesGreenland P, American College of Cardiology Foundation; American Heart Association.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
